Stax Provides Sell-Side Support to BioProcure-Prendio, Receiving Strategic Growth Investment from Primus Capital

Stax Provides Sell-Side Support to BioProcure-Prendio, Receiving Strategic Growth Investment from Primus Capital

November 3, 2023
November 3, 2023

Share

Stax is pleased to congratulate BioProcure and its sister company, Prendio, on their recent growth equity investment from Primus Capital. Stax provided sell-side support collaborating with the management teams of BioProcure and Prendio and Aeris Partners.


Since 2007, BioProcure has significantly contributed to the success of numerous global life science companies. An industry-leading provider of procure-to-pay enabled services for biotech, BioProcure offers procurement services, accounts payable support, and administrative assistance to research organizations. 

 

Prendio is a leading provider of cloud-based eProcurement SaaS and supplier marketplace solutions tailored for the life science sector. Developed by a team with over 50 years of experience in biotech procurement and lab management, Prendio software addresses the challenges faced by research teams dealing with complex procure-to-pay systems. It offers an affordable, user-friendly, and scalable solution, ultimately speeding up the progress of life science teams. 

For more details on our experience in the space, please contact the Stax team: 

BioProcure-Prendio logo
Primus logo
BioProcure-Prendio logo
Primus logo

For more details on our experience in the space, please contact the Stax team: 

Image of Rob Larson

Paul Edwards

Global Practice Lead

Image of Rob Larson

Rob Larson

Managing Director

About Stax

Stax is a global management consulting firm serving corporate and private equity clients across a broad range of industries including software/technology, industrials, business and information services, healthcare and HCIT, consumer, and tradeshows and events. 

Read More

Featured by Carta: PE is trying to figure out where AI fits into the future of healthcare
By Rob Larson September 8, 2026
Rob Larson met with Carta to discuss the growing problem of supply and demand in the US healthcare system, and how a technological revamp could be necessary. Read the full feature here.
From AI Discovery to Advertising: Where Investors Should Look Next
By Palash Misra August 14, 2026
Palash Misra explores how AI is changing the marketing landscape, with portfolio companies potentially rethinking how they reach and convert customers. Read more here.
Featured by Carta: After the “SaaS-pocalypse,” a new era begins for PE-backed software companies
By Palash Misra August 14, 2026
Palash Misra met with Carta to discuss the role of AI in SaaS investment and how investors are reprioritizing what they value in a business. Read the feature here.
Grant Thornton Stax Supports MainSail Partners in the Strategic Combination of MirrorWeb and Red Oak
August 7, 2026
Grant Thornton Stax is proud to have supported MainSail Partners in the strategic combination of MirrorWeb and Red Oak. Click to read more. ​
MSMs: Separating Durable Platforms from Disruptable Networks
By Tyler Veit & Kate Philbrick July 22, 2026
Multi-stakeholder models sit at an attractive intersection of fragmented markets and PE investors are looking to capitalize. Click here to read our latest insights on MSMs.
Grant Thornton Stax Provides Sell-side Support to Inspectorio on Investment by Apax
July 16, 2026
Grant Thornton Stax congratulates Inspectorio, a production-chain management platform, on its growth investment by Apax Digital Funds, the growth equity arm of Apax. Read more here.
Show More